177 related articles for article (PubMed ID: 18288595)
21. Role of metformin in the initiation of pharmacotherapy for type 2 diabetes: an Asian-Pacific perspective.
Chan JC; Deerochanawong C; Shera AS; Yoon KH; Adam JM; Ta VB; Chan SP; Fernando RE; Horn LC; Nguyen TK; Litonjua AD; Soegondo S; Zimmet P
Diabetes Res Clin Pract; 2007 Mar; 75(3):255-66. PubMed ID: 16876285
[TBL] [Abstract][Full Text] [Related]
22. Gliquidone versus metformin: differential effects on aorta in streptozotocin induced diabetic rats.
Tan Z; Xu Z; Gui Q; Wu W; Yang Y
Chin Med J (Engl); 2014; 127(7):1298-303. PubMed ID: 24709184
[TBL] [Abstract][Full Text] [Related]
23. Oxidative stress and endothelium influenced by metformin in type 2 diabetes mellitus.
Skrha J; Prázný M; Hilgertová J; Kvasnicka J; Kalousová M; Zima T
Eur J Clin Pharmacol; 2007 Dec; 63(12):1107-14. PubMed ID: 17874238
[TBL] [Abstract][Full Text] [Related]
24. [Infarct prevention for diabetics. To lower blood sugar is not enough].
MMW Fortschr Med; 2001 Nov; 143(46):61. PubMed ID: 11759608
[No Abstract] [Full Text] [Related]
25. Targeting the endothelium to prevent diabetes-related atherosclerosis.
Kearney MT
Diab Vasc Dis Res; 2010 Jul; 7(3):177. PubMed ID: 20699387
[No Abstract] [Full Text] [Related]
26. Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats.
Majithiya JB; Balaraman R
Life Sci; 2006 Apr; 78(22):2615-24. PubMed ID: 16318863
[TBL] [Abstract][Full Text] [Related]
27. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
Bajaj M; Jialal I
Metab Syndr Relat Disord; 2009 Apr; 7(2):79-81. PubMed ID: 19351292
[No Abstract] [Full Text] [Related]
28. The cardiovascular effects of metformin: lost in translation?
Riksen NP; Tack CJ
Curr Opin Lipidol; 2014 Dec; 25(6):446-51. PubMed ID: 25255478
[TBL] [Abstract][Full Text] [Related]
29. Antiatherogenic properties of metformin: the experimental evidence.
Mamputu JC; Wiernsperger NF; Renier G
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S71-6. PubMed ID: 14502103
[TBL] [Abstract][Full Text] [Related]
30. Anti-diabetic atherosclerosis effect of Prunella vulgaris in db/db mice with type 2 diabetes.
Hwang SM; Kim JS; Lee YJ; Yoon JJ; Lee SM; Kang DG; Lee HS
Am J Chin Med; 2012; 40(5):937-51. PubMed ID: 22928826
[TBL] [Abstract][Full Text] [Related]
31. An investigation into the pleiotropic activity of metformin. A glimpse of haemostasis.
Markowicz-Piasecka M; Sadkowska A; Huttunen KM; Podsiedlik M; Mikiciuk-Olasik E; Sikora J
Eur J Pharmacol; 2020 Apr; 872():172984. PubMed ID: 32017937
[TBL] [Abstract][Full Text] [Related]
32. Beneficial effects of metformin on haemostasis and vascular function in man.
Grant PJ
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S44-52. PubMed ID: 14502100
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of action of metformin in type 2 diabetes and associated complications: an overview.
Correia S; Carvalho C; Santos MS; Seiça R; Oliveira CR; Moreira PI
Mini Rev Med Chem; 2008 Nov; 8(13):1343-54. PubMed ID: 18991752
[TBL] [Abstract][Full Text] [Related]
34. Potential contribution of metformin to the management of cardiovascular disease risk in patients with abdominal obesity, the metabolic syndrome and type 2 diabetes.
Després JP
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S53-61. PubMed ID: 14502101
[TBL] [Abstract][Full Text] [Related]
35. Metformin and vascular protection: a cardiologist's view.
Libby P
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S117-20. PubMed ID: 14502109
[TBL] [Abstract][Full Text] [Related]
36. Metformin-like antidiabetic, cardio-protective and non-glycemic effects of naringenin: Molecular and pharmacological insights.
Nyane NA; Tlaila TB; Malefane TG; Ndwandwe DE; Owira PMO
Eur J Pharmacol; 2017 May; 803():103-111. PubMed ID: 28322845
[TBL] [Abstract][Full Text] [Related]
37. Metformin and vascular protection: a diabetologist's view.
Garber AJ
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S113-6. PubMed ID: 14502108
[TBL] [Abstract][Full Text] [Related]
38. Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies.
Kaur R; Kaur M; Singh J
Cardiovasc Diabetol; 2018 Aug; 17(1):121. PubMed ID: 30170601
[TBL] [Abstract][Full Text] [Related]
39. Prevention of Vascular Complications in Diabetes Mellitus Patients: Focus on the Arterial Wall.
Lunder M; Janić M; Šabovič M
Curr Vasc Pharmacol; 2019; 17(1):6-15. PubMed ID: 29412116
[TBL] [Abstract][Full Text] [Related]
40. Metformin therapy in diabetes: the role of cardioprotection.
El Messaoudi S; Rongen GA; Riksen NP
Curr Atheroscler Rep; 2013 Apr; 15(4):314. PubMed ID: 23423523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
